If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,990.00    -24.00 (-1.19%)
Bid:
1,990.00
Ask:
1,993.00
Spread: 3.00 (0.151%)
Market Cap: £3.34b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Holding(s) in Company

26 Nov 2019 17:06

RNS Number : 7558U
Johnson Matthey PLC
26 November 2019
 

Notification of Major Interest in Johnson Matthey Plc Ordinary Shares

 

Johnson Matthey Plc has received a notification on Form TR-1 as shown below.

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Johnson Matthey Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligation

Name

Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios

City and country of registered office (if applicable)

Edinburgh, Scotland

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

25/11/2019

6. Date on which issuer notified (DD/MM/YYYY):

26/11/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

7.51

0.00

7.51

193,533,430

Position of previous notification (if

applicable)

7.91

0.00

7.91

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BZ4BQC70

N/A

14,528,304

N/A

7.51

SUBTOTAL 8. A

14,528,304

7.51

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

Exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Standard Life Investments Limited

Standard Life Aberdeen plc

Aberdeen Asset Management PLC

Aberdeen Asset Investment Group Limited

Aberdeen Asset Investments Limited

Standard Life Aberdeen plc

Aberdeen Asset Management PLC

Aberdeen Asset Managers Limited

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Aberdeen Standard Capital Limited

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Aberdeen Standard Capital Limited

Aberdeen Standard Capital International Limited

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Ignis Asset Management Limited

Ignis Investment Services Limited

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

In reference to Section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.

 

This disclosure is to reflect the fact that the voting rights effectively held indirectly by the underlying intermediate holding company Standard Life Investments (Holdings) Limited ("SLIHL") decreased below the 5% threshold due to trading on 25 November 2019. Prior to this crossing, SLIHL held 5.17% of the delegated voting rights.

 

 

Place of completion

Aberdeen, United Kingdom

Date of completion

26/11/2019

 

 

Contact Name:

 

Victoria Barlow, Deputy Company Secretary, Johnson Matthey Plc

 

Contact Telephone Number:

 

020 7269 8431

 

 

26 November 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLBFBRTMBMTBJL
Date   Source Headline
3rd Jul 20243:24 pmRNSHolding(s) in Company
3rd Jul 20247:00 amRNSShare buyback programme
2nd Jul 20243:04 pmRNSHolding(s) in Company
1st Jul 20242:38 pmRNSCompletion of Medical Device Components sale
1st Jul 20247:00 amRNSDirectorate Change
27th Jun 20245:54 pmRNSHolding(s) in Company
27th Jun 202412:03 pmRNSHolding(s) in Company
27th Jun 20247:00 amRNSJohnson Matthey: PGM Services seminar
25th Jun 202410:35 amRNSHolding(s) in Company
20th Jun 202412:24 pmRNSDirector/PDMR Shareholding
14th Jun 20243:00 pmRNSHolding(s) in Company
6th Jun 20249:00 amRNSAnnual Financial Report
28th May 202410:13 amRNSHolding(s) in Company
23rd May 20247:00 amRNSJohnson Matthey Full Year Results
21st May 20245:04 pmRNSHolding(s) in Company
20th May 20245:04 pmRNSHolding(s) in Company
16th May 20244:43 pmRNSDirector/PDMR Shareholding
16th May 20244:11 pmRNSHolding(s) in Company
14th May 202412:05 pmRNSHolding(s) in Company
3rd May 20243:31 pmRNSHolding(s) in Company
2nd May 20249:00 amRNSHolding(s) in Company
22nd Apr 20243:39 pmRNSHolding(s) in Company
18th Apr 20245:33 pmRNSDirector/PDMR Shareholding
17th Apr 20243:07 pmRNSHolding(s) in Company
10th Apr 20243:10 pmRNSHolding(s) in Company
10th Apr 20249:47 amRNSHolding(s) in Company
9th Apr 20249:00 amRNSHolding(s) in Company
8th Apr 20249:00 amRNSHolding(s) in Company
3rd Apr 20245:16 pmRNSHolding(s) in Company
2nd Apr 20249:01 amRNSHolding(s) in Company
2nd Apr 20249:00 amRNSHolding(s) in Company
27th Mar 20241:46 pmRNSHolding(s) in Company
22nd Mar 20243:11 pmRNSHolding(s) in Company
21st Mar 202412:13 pmRNSDirector/PDMR Shareholding
20th Mar 20247:00 amRNSJohnson Matthey sale of Medical Device Components
18th Mar 20243:05 pmRNSHolding(s) in Company
18th Mar 20242:32 pmRNSHolding(s) in Company
12th Mar 20245:12 pmRNSHolding(s) in Company
12th Mar 20249:00 amRNSHolding(s) in Company
11th Mar 20249:00 amRNSHolding(s) in Company
7th Mar 20244:20 pmRNSHolding(s) in Company
22nd Feb 20244:53 pmRNSDirector/PDMR Shareholding
20th Feb 20243:57 pmRNSHolding(s) in Company
19th Feb 20243:12 pmRNSHolding(s) in Company
15th Feb 20249:54 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSHolding(s) in Company
9th Feb 202412:31 pmRNSDirector/PDMR Shareholding
8th Feb 20242:17 pmRNSHolding(s) in Company
1st Feb 20244:08 pmRNSHolding(s) in Company
29th Jan 20243:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.